Redwood City, CA, United States of America

Chrisopher M Levins

This inventor holds 1 USPTO granted patent. Top assignee: Gilead Pharmasset LLC. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chrisopher M Levins. Retrieved from https://idiyas.com/inventor/chrisopher-m-levins

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Christopher M. Levins: Innovator in Antiviral Compounds

Introduction

Christopher M. Levins is a notable inventor based in Redwood City, California. He has made significant contributions to the field of antiviral research, particularly through his innovative processes for preparing antiviral compounds. His work is essential in the ongoing fight against viral infections.

Latest Patents

Christopher holds one patent titled "Processes for preparing antiviral compounds." This patent provides detailed processes for the preparation of a compound that is useful as an antiviral agent. The disclosure also includes compounds that serve as synthetic intermediates, showcasing his expertise in medicinal chemistry.

Career Highlights

Christopher is currently employed at Gilead Pharmasset LLC, a leading biopharmaceutical company known for its focus on antiviral therapies. His role at Gilead has allowed him to contribute to groundbreaking research and development in the field of antiviral medications.

Collaborations

Some of Christopher's coworkers include Kevin McCormack Allan and Shinji Fujimori. Their collaborative efforts in research and development have further advanced the understanding and treatment of viral diseases.

Conclusion

Christopher M. Levins is a dedicated inventor whose work in antiviral compounds is making a significant impact in the medical field. His contributions are vital for the development of effective antiviral therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…